Kiran Mazumdar-Shaw warns against long-term GLP-1 use, urges caution over weight-loss drugs, says 'for those who are not diabetic or clinically obese...'Nithin Kamath questions India's slow adoption of affordable GLP-1 weight-loss drugs, despite rising obesity. He points to challenges like l...
27 Jun, 2026, 09.43 PM IST
India’s GLP-1 boom loses steam as price war, weak retention hit generic weight-loss drug salesInitial excitement for India's generic weight-loss drugs is fading. Domestic manufacturers are lowering sales targets due to slower-than-ex...
26 Jun, 2026, 03.22 PM IST
India’s next big challenge: From welfare delivery to human developmentThe National Family Health Survey 2023-24 reveals India's success in expanding welfare delivery and essential service access, reaching near...
23 Jun, 2026, 11.38 PM IST
Stress, poor sleep and processed food are driving heart attacks in young Indians: Ramakanta PandaYoung Indian professionals, particularly in IT and finance, are facing a heart disease crisis due to unhealthy lifestyles. Leading cardiac ...
23 Jun, 2026, 03.29 PM IST
Hara Hachi Bu: The Japanese secret parents teach their children that may explain why obesity rates remain so low in JapanDiscover "Hara Hachi Bu," a centuries-old Japanese practice from Okinawa, teaching to eat until 80% full. This simple principle, passed thr...
21 Jun, 2026, 05.29 PM IST
Anupam Kher is 71 and fitter than ever. His every day food costs just Rs 80 a kg but ‘not very tasty’. Science says it can help lose weightVeteran actor Anupam Kher, aged 71, showcases remarkable fitness. A recent workout video went viral, impressing fans. Kher shared his diet,...
19 Jun, 2026, 01.33 PM IST
India makes gains in child, maternal health but nutrition challenges persist: SBI reportIndia's latest health survey reveals significant improvements in maternal care and child vaccination rates. Stunting among children has see...
17 Jun, 2026, 11.26 AM IST
Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...
16 Jun, 2026, 06.27 PM IST
Indian pharma leaving generics era behind, but the Street hasn't caught up yet: Nandan KulkarniIndian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...
16 Jun, 2026, 02.24 PM IST
Cipla appoints health chief Shivam Puri to lead One India businessCipla has appointed Shivam Puri as the new Chief Executive Officer for its One India Business. This significant leadership change will take...
16 Jun, 2026, 01.21 PM IST
The hidden cost of looking better: What health insurance covers, and what it leaves you to payRising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...
15 Jun, 2026, 11.08 AM IST
India risks becoming "unhealthier before it becomes richer," CEA V Anantha Nageswaran warnsIndia faces a health challenge before achieving wealth. Chief Economic Advisor V Anantha Nageswaran points to rising obesity and sedentary ...
14 Jun, 2026, 05.29 PM IST
India's weight-loss drug boom raises questions over healthcare prioritiesIndia's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...
12 Jun, 2026, 11.48 PM IST
India needs to remain attractive for innovation-led investment: Judith Love, NovartisWith an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The com...
12 Jun, 2026, 12.37 AM IST
Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
11 Jun, 2026, 10.31 AM IST
India's weight-loss market grows upThe landscape of India's anti-obesity drug market has reached a point of refinement. While there are affordable generic options, their upta...
10 Jun, 2026, 11.28 PM IST
India’s anti-obesity drug market sees slower growth after initial surge in generic semaglutide salesIndia's anti-obesity drug market sees a slowdown after initial generic semaglutide sales. Demand has eased from its peak, with growth moder...
09 Jun, 2026, 05.30 AM IST